Condition: Non-cystic Fibrosis Bronchiectasis · Sponsor: Sanofi
This is a randomized, double-blind, placebo-controlled study to measure the reduction in mucus plug score at 24 weeks of treatment with SAR445399 compared with placebo in adult participants aged 18 to 80 years with non-cystic fibrosis bronchiectasis (NCFB).
This description comes directly from the study's public registry record.
Trial Transparency email recommended (Toll free for US & Canada) · 800-633-1610 · Contact-US@sanofi.com
Always discuss trial participation with your own doctor first.
| Pulmonary Associates - Phoenix - East McDowell Road- Site Number : 8400008 | Phoenix, Arizona, United States | Recruiting |
| Advanced Pulmonary Research Institute- Site Number : 8400001 | Loxahatchee Groves, Florida, United States | Recruiting |
| Hull and Hull Medical Specialists- Site Number : 8400002 | Plantation, Florida, United States | Recruiting |
| Clinical Research Associates of Central Pennsylvania- Site Number : 8400006 | DuBois, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07547436